참고문헌
- Statistics Korea. Deaths and death rates. In: The Cause of Death Statistics 2011. Seoul: Statistics Korea; 2012. p.3
- Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 2005; 46(11): 1978-1985 https://doi.org/10.1016/j.jacc.2005.06.082
- Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis 1999; 147(2): 213-225 https://doi.org/10.1016/S0021-9150(99)00346-9
- Melgarejo E, Medina MA, Sánchez-Jimenez F, Urdiales JL. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 2009; 41(5): 998-1001 https://doi.org/10.1016/j.biocel.2008.07.018
- Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 1991; 88(12): 5252-5256 https://doi.org/10.1073/pnas.88.12.5252
- Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88(4): 1121-1127 https://doi.org/10.1172/JCI115411
- Seli E, Pehlivan T, Selam B, Garcia-Velasco JA, Arici A. Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. Fertil Steril 2002; 77(3): 542-547 https://doi.org/10.1016/S0015-0282(01)03223-X
- de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003; 107(5): 690-695 https://doi.org/10.1161/01.CIR.0000049742.68848.99
- Serrano-Martínez M, Palacios M, Lezaun R. Monocyte chemoattractant protein-1 concentration in coronary sinus blood and severity of coronary disease. Circulation 2003; 108(10): e75 https://doi.org/10.1161/01.CIR.0000089100.20182.B7
- Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D'Annunzio E, Conti P, Chiarelli F, Cuccurullo F, Mezzetti A. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001; 21(3): 327- 334 https://doi.org/10.1161/01.ATV.21.3.327
- Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA, de Lemos JA. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004; 44(9): 1812-1818 https://doi.org/10.1016/j.jacc.2004.07.047
- Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP- 1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259(2): 344-348 https://doi.org/10.1006/bbrc.1999.0796
- Kroner A, Mäurer M, Loserth S, Kleinschnitz C, Hemmer B, Rosche B, Toyka KV, Rieckmann P. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis. Tissue Antigens 2004; 64(1): 70-73 https://doi.org/10.1111/j.1399-0039.2004.00240.x
- Krüger B, Schröppel B, Ashkan R, Marder B, Zülke C, Murphy B, Krämer BK, Fischereder M. A monocyte chemoattractant protein- 1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol 2002; 13(10): 2585-2589 https://doi.org/10.1097/01.ASN.0000031701.53792.54
- Szalai C, Duba J, Prohászka Z, Kalina A, Szabó T, Nagy B, Horváth L, Császár A. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 2001; 158(1): 233-239 https://doi.org/10.1016/S0021-9150(01)00423-3
- Tabara Y, Kohara K, Yamamoto Y, Igase M, Nakura J, Kondo I, Miki T. Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 2003; 26(9): 677-683 https://doi.org/10.1291/hypres.26.677
- Buraczynska M, Bednarek-Skublewska A, Buraczynska K, Ksiazek A. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients. Cytokine 2008; 44(3): 361-365 https://doi.org/10.1016/j.cyto.2008.10.001
- Jeon HJ, Choi HJ, Park BH, Lee YH, Oh T. Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes. Yonsei Med J 2013; 54(3): 621-625 https://doi.org/10.3349/ymj.2013.54.3.621
- Moon JY, Jeong L, Lee S, Jeong K, Lee T, Ihm CG, Suh J, Kim J, Jung YY, Chung JH. Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus. J Korean Med Sci 2007; 22(5): 810-814 https://doi.org/10.3346/jkms.2007.22.5.810
- Stang J, Zephier EM, Story M, Himes JH, Yeh JL, Welty T, Howard BV. Dietary intakes of nutrients thought to modify cardiovascular risk from three groups of American Indians: the Strong Heart Dietary Study, Phase II. J Am Diet Assoc 2005; 105(12): 1895-1903 https://doi.org/10.1016/j.jada.2005.09.003
- Tell GS, Evans GW, Folsom AR, Shimakawa T, Carpenter MA, Heiss G. Dietary fat intake and carotid artery wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1994; 139(10): 979-989
- de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99(6): 779- 785 https://doi.org/10.1161/01.CIR.99.6.779
- Kreijkamp-Kaspers S, Kok L, Bots ML, Grobbee DE, Lampe JW, van der Schouw YT. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr 2005; 81(1): 189-195
- Jiang R, Jacobs DR Jr, Mayer-Davis E, Szklo M, Herrington D, Jenny NS, Kronmal R, Barr RG. Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am J Epidemiol 2006; 163(3): 222-231
- Park HJ. Association of MCP-1 polymorphism with cardiovascular risk factors in Korean elderly [Ph.D. thesis]. Seoul: Ewha Womans University; 2007
- The Korean Nutrition Society, Korean Nutrition Information Center. Nutritional assessment program, 'CAN pro 3.0' [CDROM]. Seoul: The Korean Nutrition Society; 2006
- The Korean Nutrition Society. Dietary reference intakes for Koreans. Seoul: The Korean Nutrition Society; 2010
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6): 499-502
- Kitamoto S, Egashira K. Anti-monocyte chemoattractant protein- 1 gene therapy for cardiovascular diseases. Expert Rev Cardiovasc Ther 2003; 1(3): 393-400 https://doi.org/10.1586/14779072.1.3.393
- Okopień B, Haberka M, Cwalina L, Kowalski J, Belowski D, Madej A, Zieliński M, Krysiak R, Labuzek K, Kalina Z, Herman ZS. Plasma cytokines as predictors of coronary heart disease. Res Commun Mol Pathol Pharmacol 2002; 112(1-4): 5-15
- Ozyürek AR, Gürses D, Ulger Z, Levent E, Bakiler AR, Berdeli A. Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis. Clin Rheumatol 2007; 26(4): 546- 550 https://doi.org/10.1007/s10067-006-0347-6
- Kim HL, Yang SH, Oh YK, Lee JE, Oh JE, Yoon HJ, Kim YS, Ahn CR, Han JS, Kim SG, Lee JS. The effects of polymorphism in the MCP-1 gene regulatory region on MCP-1 expression and the manifestation of lupus nephritis. Korean J Nephrol 2002; 21(1): 137-144
- Pae CU, Kim JJ, Yu HS, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH. Monocyte chemoattractant protein-1 promoter -2518 polymorphism may have an influence on clinical heterogeneity of bipolar I disorder in the Korean population. Neuropsychobiology 2004; 49(3): 111-114 https://doi.org/10.1159/000076718
- Zhong C, Luzhan Z, Genshan M, Jiahong W, Xiaoli Z, Qi Q. Monocyte chemoattractant protein-1-2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease. Mol Biol Rep 2010; 37(1): 7-12 https://doi.org/10.1007/s11033-009-9479-5
- Pola R, Flex A, Gaetani E, Proia AS, Papaleo P, Di Giorgio A, Straface G, Pecorini G, Serricchio M, Pola P. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians. Exp Gerontol 2004; 39(8): 1249- 1252 https://doi.org/10.1016/j.exger.2004.05.001
- Zietz B, Büchler C, Herfarth H, Müller-Ladner U, Spiegel D, Schölmerich J, Schäffler A. Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism. Diabetes Obes Metab 2005; 7(5): 570-578 https://doi.org/10.1111/j.1463-1326.2004.00436.x
- Aguilar F, González-Escribano MF, Sánchez-Román J, Núñez- Roldán A. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 2001; 58(5): 335-338 https://doi.org/10.1034/j.1399-0039.2001.580508.x
- Penz P, Bucova M, Lietava J, Blazicek P, Paulovicova E, Mrazek F, Bernadic M, Buckingham TA, Petrek M. MCP-1 -2518 A/G gene polymorphism is associated with blood pressure in ischemic heart disease asymptomatic subjects. Bratisl Lek Listy 2010; 111 (8): 420-425
- Sonnenberg L, Pencina M, Kimokoti R, Quatromoni P, Nam BH, D'Agostino R, Meigs JB, Ordovas J, Cobain M, Millen B. Dietary patterns and the metabolic syndrome in obese and nonobese Framingham women. Obes Res 2005; 13(1): 153-162 https://doi.org/10.1038/oby.2005.20
- Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002; 25(1): 148-198 https://doi.org/10.2337/diacare.25.1.148
- Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337 (21): 1491-1499 https://doi.org/10.1056/NEJM199711203372102
- Shishehbor F, Roche HM, Gibney MJ. The effect of low and moderate fat intakes on the postprandial lipaemic and hormonal responses in healthy volunteers. Br J Nutr 1999; 81(1): 25-30
- German JB. Genetic dietetics: nutrigenomics and the future of dietetics practice. J Am Diet Assoc 2005; 105(4): 530-531 https://doi.org/10.1016/j.jada.2005.02.034
- Tanasescu M, Cho E, Manson JE, Hu FB. Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. Am J Clin Nutr 2004; 79(6): 999-1005
피인용 문헌
- Monocyte chemoattractant protein-1 polymorphism interaction with spirulina immunomodulatory effects in healthy Korean elderly: A 16 week, double-blind randomized clinical trial vol.11, pp.4, 2017, https://doi.org/10.4162/nrp.2017.11.4.290